Market closedNon-fractional

Fortrea Holdings/FTRE

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Fortrea Holdings

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Ticker

FTRE

Sector

Healthcare

Trading on

NASDAQ

Industry

Life Sciences Tools and Services

Headquarters

Durham, United States

Employees

16,000

Fortrea Holdings Metrics

BasicAdvanced
$2.1B
Market cap
-
P/E ratio
-$1.31
EPS
-
Beta
-
Dividend rate
$2.1B
1.471
1.263
101.049
105.43
0.42%
0.56%
-3.65%
0.69
1.33
-2.56
19.17
2.20%
-167.62%

What the Analysts think about Fortrea Holdings

Analyst Ratings

Majority rating from 9 analysts.
Buy

Fortrea Holdings Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-15.25% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$662M
-14.61%
Net income
-$101M
180.56%
Profit margin
-15.25%
228.66%

Fortrea Holdings Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 618.54%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.24
$0.19
-$0.04
-
Expected
$0.16
$0.24
$0.01
$0.06
Surprise
48.84%
-20.67%
-618.54%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Fortrea Holdings stock?

Fortrea Holdings (FTRE) has a market cap of $2.1B as of July 05, 2024.

What is the P/E ratio for Fortrea Holdings stock?

The price to earnings (P/E) ratio for Fortrea Holdings (FTRE) stock is 0 as of July 05, 2024.

Does Fortrea Holdings stock pay dividends?

No, Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Fortrea Holdings dividend payment date?

Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders.

What is the beta indicator for Fortrea Holdings?

Fortrea Holdings (FTRE) does not currently have a Beta indicator.

Buy or sell Fortrea Holdings stock

Buy or sell Fortrea Holdings stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing